iSpecimen Named to Fast Company’s World’s Most Innovative Companies Annual List for 2023
March 02 2023 - 6:00AM
iSpecimen Inc. (Nasdaq: ISPC), an online global marketplace that
connects scientists in need of biospecimens for medical research
with a network of healthcare specimen providers (“iSpecimen”), has
been named to Fast Company’s annual list of the World’s Most
Innovative Companies as part of the biotech category for 2023. Fast
Company is a business magazine that focuses on technology, business
and design.
“Every day, healthcare institutions are throwing
away valuable biospecimens they no longer need. However, what ends
up disposed can actually serve as valuable resources for medical
researchers in need of these types of biospecimens,” said Tracy
Curley, CEO of iSpecimen. “Our team has worked tirelessly to solve
this disconnect and eliminate the cumbersome and time-consuming
process for researchers, who are our customers, to obtain this
critical biomaterial. Being named to Fast Company’s World’s Most
Innovative Companies list is a testament to our continued success
in working to reinvent the biospecimen procurement process that
will in turn help to further accelerate medical discovery.”
The iSpecimen Marketplace® allows life science
researchers to search for and find millions of human biospecimens
across iSpecimen’s global, proprietary network of healthcare
providers, who have access to large, diverse patient populations
and specimens. iSpecimen’s proprietary, cloud-based technology
enables scientists to intuitively search via a Google-like search
bar for biospecimens based on demographic traits, medical
conditions, procedures, blood type, country of collection and much
more.
iSpecimen addresses the highly fragmented and
inefficient biospecimen procurement market that makes compliance
and contracting increasingly complex and challenging for
researchers to manage themselves. The iSpecimen Marketplace
compliantly connects each side of this fragmented market to reduce
the costs, time and risks for both suppliers and customers in the
biospecimen supply chain.
The World’s Most Innovative Companies is Fast
Company’s signature franchise and one of its most highly
anticipated editorial efforts of the year. Fast Company will host
its third annual Most Innovative Companies Summit on April 19-20,
2023. The virtual summit celebrates the Most Innovative Companies
in business and provides an inside look at cutting-edge business
trends and what it takes to innovate in 2023. Fast Company’s Most
Innovative Companies issue (March/April 2023) is available online
here, as well as in-app form via iTunes, and on newsstands
beginning March 14, 2023.
About iSpecimeniSpecimen
(Nasdaq: ISPC) offers an online marketplace for human biospecimens,
connecting scientists in commercial and non-profit organizations
with healthcare providers that have access to patients and
specimens needed for medical discovery. Proprietary, cloud-based
technology enables scientists to intuitively search for specimens
and patients across a federated partner network of hospitals, labs,
biobanks, blood centers and other healthcare organizations. For
more information, please visit www.ispecimen.com.
For further information, please
contact:
Investor ContactKCSA Strategic
CommunicationsAllison SossiSpecimen@kcsa.com
Media ContactsKCSA Strategic
CommunicationsRaquel Cona / Michaela FawcettiSpecimen@kcsa.com
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Dec 2024 to Jan 2025
iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Jan 2024 to Jan 2025